Showing 4791-4800 of 20470 results for "".
- Conversational AI Agent Eases Psychiatric Symptoms In Randomized Trialhttps://reachmd.com/news/conversational-ai-psychiatric-symptoms-trial/2486797/Key Takeaways Among college students, anxiety was associated with reduced anxiety with a conversational AI platform compared to face-to-face therapy. Perceived digital therapeutic alliance in the AI arm was associated with engagement and indirectly wit
- Hydrafacial Parent Company Rebrands to SkinHealth Systemshttps://reachmd.com/news/hydrafacial-parent-company-rebrands-to-skinhealth-systems/2486793/BeautyHealth Company has announced a corporate rebrand to SkinHealth Systems, reflecting a strategic repositioning toward a clinically oriented, science-backed medical aesthetics platform. The change is effective immediately, with the company continuing to trade on the Nasdaq under its existing t
- Lumbar Discectomy Review Maps Early Pain Relief And Opioid Sparinghttps://reachmd.com/news/lumbar-discectomy-review-maps-early-pain-relief-and-opioid-sparing/2486779/Key Takeaways Paracetamol, NSAIDs, epidural and intrathecal anaesthetics, local infiltration, nerve blocks, gabapentin, and pregabalin were associated with lower 24-hour opioid consumption. Lower pain scores at 6 and 24 hours were associated with parac
- Home-Based Prehabilitation In Frail Older Surgical Patientshttps://reachmd.com/news/home-based-prehabilitation-in-frail-older-surgical-patients/2486782/Key Takeaways The primary analyses showed no between-group differences in postoperative disability or in-hospital complications. The intervention was a home-based, multimodal, coach-supported program, and adherence was feasible but incomplete, with med
- High-Dose Oral Rifampin in Adults With Tuberculous Meningitishttps://reachmd.com/news/high-dose-oral-rifampin-in-adults-with-tuberculous-meningitis/2486783/Key Takeaways Adults assigned to the higher cumulative rifampin dose did not show a survival advantage at 6 months. Drug-induced liver injury was reported more often with intensified rifampin, and no deaths from liver injury were reported. The
- Omalizumab Linked to 16-Week Gains in Severe Allergic Asthmahttps://reachmd.com/news/omalizumab-linked-to-16-week-gains-in-severe-allergic-asthma/2486790/Key Takeaways Omalizumab was associated with better asthma control, less dyspnea, and a longer 6-minute walk distance at week 16. FeNO was lower, serum IgE was higher, and peak expiratory flow and mid- to small-airway flow measures improved. L
- Rilzabrutinib Phase 2 Asthma Trial Reports Mixed Efficacy Signalhttps://reachmd.com/news/rilzabrutinib-phase-2-asthma-trial-reports-mixed-efficacy-signal/2486774/Key Takeaways Loss-of-asthma-control events were numerically lower with both rilzabrutinib doses than with placebo, but statistical significance was not reached. Asthma control improved by week 2 and remained better than placebo through week 12 in both
- SCREESCO Trial Compares Colonoscopy, FIT, and Usual Carehttps://reachmd.com/news/screesco-trial-compares-colonoscopy-fit-and-usual-care/2486775/Key Takeaways In 278,280 adults aged 60 years, randomization assigned once-only colonoscopy, two rounds of low-cutoff two-stool FIT, or usual care, and participation reached 35% and 55% among invited groups. Overall colorectal cancer incidence was simi
- Five-Year Outcomes of Aragonite Scaffold vs Standard Care for Knee Lesionshttps://reachmd.com/news/five-year-outcomes-of-aragonite-scaffold-vs-standard-care-for-knee-lesions/2486776/Key Takeaways Greater 5-year improvement in overall KOOS was observed with the aragonite-based implant than with standard surgical care. The implant group had a 74.7% overall KOOS responder rate versus 29.6% with standard surgical care, while treatment
- AAD Pediatric Guidelines Give Strong Backing to Roflumilast Creamhttps://reachmd.com/news/aad-pediatric-guidelines-give-strong-backing-to-roflumilast-cream/2486794/Arcutis Biotherapeutics announced that ZORYVE (roflumilast) cream has received a strong recommendation in the American Academy of Dermatology (AAD) clinical practice guidelines for pediatric atopic dermatitis (AD), marking inclusion in the organization’s first guid